Meet the Next Mega Blockbuster Heart Drug
Novartis is getting ready to steal a lot of hearts with its newest drug. The FDA has approved Entresto tablets for the treatment of heart failure.
All Work
Chris Lange
Is ConocoPhillips Now Grossly Undervalued?
Despite crude oil prices falling to the low $50 range, ConocoPhillipsis still making a good impression on analysts.
Will Alcoa Be an Earnings Season Barometer This Time?
Falling aluminum prices over the past year have absolutely demolished Alcoa stock. There is no doubt that Alcoa is in desperate need of a turnaround.
United Airlines Resumes Flights
United Continental experienced technical difficulties Wednesday morning and was forced to halt its flights temporarily.
Key Analyst Raises Apple iPhone Targets but Ignores Apple Watch
Apple is continuing to improve its products, and the outlook, according to Canaccord Genuity, is incredibly positive.
Albertsons Files for IPO
Albertsons Companies has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
Gensight Biologics Files for Initial Public Offering
Gensight Biologics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
The Container Store Finally Does Not Tank on Earnings
The Container Store reported better-than-expected fiscal second-quarter earnings after the markets closed Tuesday.
Ooma Prices Initial Public Offering
ThinkstockOoma, Inc. filed an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) to price its initial public offering (IPO). The expected price range for the offering is $16 to $18 for 5…
MCBC Prices IPO
MCBC Holdings Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
What to Expect From Alcoa Earnings
Alcoa is scheduled to report its second-quarter financial results after the markets close Wednesday.
Horizon Pharma Makes Hostile Bid to Acquire DepoMed
Horizon Pharma has gone hostile in its attempt to take over DepoMed. These companies have been in talks since March, but an agreement was never reached.
How Analysts Rate AMD After Its Warning
As a result of the surprise update from Advanced Micro Devices, analysts have taken this opportunity to readjust their forecasts.
Why the Duke Dividend Hike Matters So Much
Duke Energy has announced that it will increase its dividend 3.8% to a quarterly payout of $0.825.
Meet the Newest ETF in Cybersecurity
The First Trust Nasdaq CEA Cybersecurity ETF, a new exchange traded fund, hits the market Tuesday, July 7.
5 Big Upcoming FDA Decisions Expected in July
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
Will the Beatings at AMD Be Felt Elsewhere?
Advanced Micro Devices had its shares halted in the after-hours trading session on Monday for a warning to its investors regarding its upcoming earnings report.
Big Downside Ahead for Raptor?
ThinkstockRaptor Pharmaceuticals Corp. (NASDAQ: RPTP) was downgraded by Oppenheimer to an Underperform rating from Perform with an $8 price target, implying a downside of about 45% from current prices. Ultimately the brokerage firm recommends…
What to Expect From PepsiCo Earnings
PepsiCois scheduled to report its second-quarter financial results before the markets open Thursday.
Is Gilead Headed Lower From Here?
Merrill Lynch recently updated its view on Gilead Sciences, maintaining its Underperform rating for the stock but raising its price objective